More than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's ...

Vermont has the second lowest state fatality rate in the US (147.9 per 100K; Hawaii 113.5/100K). Mississippi (465.6/100K) and ...

This year there’s an unholy alliance of health risks for festival goers, with doctors concerned about one nasty disease in ...

The adjusted incidence of transmission of influenza virus by day 5 that resulted in symptoms was 5.8% with baloxavir and 7.6% with placebo, but this difference was not significant (adjusted OR 0. ...

Kylian Mbappe of Real Madrid has been hospitalized with acute gastroenteritis, a significant blow to both the team and the inaugural tournament. The i ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on ...

Norovirus GII.17 accounted for < 10% of outbreaks in the US 2022-23 season, but rose to 75% during the 2024-25 season, passing the number of GII.4 outbreaks.

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.

In previous years, the U.S. saw norovirus outbreaks increase around December, which marked the start of the season of the virus. Between 2011 and 2024, GII.4 viruses caused less than 50% of US ...

Dr. Mallika Marshall has more on both stories in this edition of Healthwatch. Musk jokes about reconsidering stance on Big Beautiful Bill after Schiff's praise John Wick Boss Slams Spin-Off Series ...

Whether the upcoming norovirus season will surge early again this year may be anyone’s guess. But, scientists say there’s a new strain to worry about (Getty Images for NYCWFF) ...